This website is intended for Healthcare Professionals. If you are not a Healthcare Professional please click here

Accessibility Statement for Boehringer Ingelheim websites

Boehringer Ingelheim is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. We are actively working to increase the accessibility and usability of our website and in doing so adhere to many of the available standards and guidelines. These guidelines explain how to make web content more accessible for people with disabilities. Conformance with these guidelines will help make the internet more user-friendly for all people. We are continually seeking out solutions that will bring all areas of the Site up to the same level of overall web accessibility.

We try to offer a clear navigation structure that helps you to find the content you are looking for in an easy and quick way.

Links contain title attributes that describe the content and make sense out of context.

The use of short sentences and paragraphs and multiple entries points to additional information sources.

In the meantime, should you experience any difficulty in accessing the Boehringer Ingelheim website, please do not hesitate to contact us.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (Freephone) or PV_local_uk_ireland@boehringer-ingelheim.com
The information on this website has been created by Boehringer Ingelheim. For product information, including patient leaflets and summary of product characteristics, please see Product Information section.
PC-GB-100901 V1 - October 2020